Skip to main content

Vir Biotechnology, Inc.

VIR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001706431

No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Vir Biotechnology, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
210
+36 vs. Q3 2021
Shares held
78.1M
+3.63M (+4.9%) vs. Q3 2021
Total value
$3.25B
+$11.6M (+0.4%) vs. Q3 2021
New holders
59
77 more added
Sold out
23
57 more reduced

1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 210 institutions
Q1 2021: 157 institutionsQ2 2021: 166 institutionsQ3 2021: 175 institutionsQ4 2021: 210 institutionsQ1 2022: 204 institutionsQ2 2022: 214 institutionsQ3 2022: 221 institutionsQ4 2022: 225 institutionsQ1 2023: 234 institutionsQ2 2023: 227 institutionsQ3 2023: 215 institutionsQ4 2023: 207 institutionsQ1 2024: 210 institutionsQ2 2024: 215 institutionsQ3 2024: 197 institutionsQ4 2024: 208 institutionsQ1 2025: 234 institutionsQ2 2025: 213 institutionsQ3 2025: 213 institutionsQ4 2025: 218 institutionsQ1 2026: 252 institutionsQ2 2026: 237 institutions
Value heldQ4 2021: $3.25B
Q1 2021: $3.87BQ2 2021: $3.64BQ3 2021: $3.24BQ4 2021: $3.25BQ1 2022: $2.09BQ2 2022: $2.20BQ3 2022: $1.68BQ4 2022: $2.18BQ1 2023: $2.06BQ2 2023: $2.23BQ3 2023: $827.4MQ4 2023: $887.2MQ1 2024: $901.0MQ2 2024: $783.1MQ3 2024: $656.3MQ4 2024: $652.0MQ1 2025: $604.5MQ2 2025: $558.5MQ3 2025: $610.8MQ4 2025: $696.5MQ1 2026: $1.25BQ2 2026: $1.49B
Institutions holding VIR and their total value by quarter
QuarterHoldersValue
Q2 2026237$1.49B
Q1 2026252$1.25B
Q4 2025218$696.5M
Q3 2025213$610.8M
Q2 2025213$558.5M
Q1 2025234$604.5M
Q4 2024208$652.0M
Q3 2024197$656.3M
Q2 2024215$783.1M
Q1 2024210$901.0M
Q4 2023207$887.2M
Q3 2023215$827.4M
Q2 2023227$2.23B
Q1 2023234$2.06B
Q4 2022225$2.18B
Q3 2022221$1.68B
Q2 2022214$2.20B
Q1 2022204$2.09B
Q4 2021210$3.25B
Q3 2021175$3.24B
Q2 2021166$3.64B
Q1 2021157$3.87B

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Vir Biotechnology, Inc.; share changes are against Q3 2021.

Institutions holding VIR in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Alaska Permanent Fund Corp2,300,000$79.0M1.44%−1,272,438−35.6%Reduced
Point72 Asset Management, L.P.2,055,100$86.0M0.38%+2,033,400+9,370.5%Added
State Street Corp2,528,107$105.9M0.01%+240,241+10.5%Added
Alliancebernstein L.P.2,620,753$109.7M0.04%+483,261+22.6%Added
Baillie Gifford & Co3,915,501$163.9M0.09%+15,809+0.4%Added
BlackRock Inc.5,308,049$222.2M0.01%+148,420+2.9%Added
Capital International Investors5,505,566$230.5M0.05%−3,218,090−36.9%Reduced
Temasek Holdings (Private) Ltd5,537,291$231.8M0.84%−223,754−3.9%Reduced
Vanguard Group Inc7,330,131$306.9M0.01%+109,814+1.5%Added
SB Investment Advisers (UK) Ltd22,216,644$930.2M2.71%−400,022−1.8%Reduced
Bank of Montreal0$00.00%−205,896−100.0%Sold out
Alps Advisors Inc0$00.00%−160,089−100.0%Sold out
SG3 Management, LLC0$00.00%−81,500−100.0%Sold out
Tekla Capital Management LLC0$00.00%−81,400−100.0%Sold out
Bronte Capital Management Pty Ltd.0$00.00%−74,920−100.0%Sold out
Twinbeech Capital LP0$00.00%−55,974−100.0%Sold out
Northside Capital Management, LLC0$00.00%−37,132−100.0%Sold out
Engineers Gate Manager LP0$00.00%−33,864−100.0%Sold out
Belpointe Asset Management LLC0$00.00%−25,099−100.0%Sold out
Trellus Management Company, LLC0$00.00%−24,464−100.0%Sold out
DC Investments Management, LLC0$00.00%−20,000−100.0%Sold out
Seven Eight Capital, LP0$00.00%−11,957−100.0%Sold out
Pekin Hardy Strauss, Inc.0$00.00%−11,500−100.0%Sold out
Cowen and Company, LLC0$00.00%−10,850−100.0%Sold out
AQR Capital Management LLC0$00.00%−9,498−100.0%Sold out
Golden Green, Inc.0$00.00%−4,980−100.0%Sold out
Acadian Asset Management LLC0$00.00%−4,655−100.0%Sold out
Cypress Point Wealth Management, LLC0$00.00%−4,261−100.0%Sold out
Penserra Capital Management LLC0$00.00%−2,990−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−1,012−100.0%Sold out
Brewin Dolphin Ltd0$00.00%−820−100.0%Sold out
Asset Dedication, LLC0$00.00%−100−100.0%Sold out
D'Orazio & Associates, Inc.0$00.00%−1−100.0%Sold out
Freed Investment Group––––Not filed